Skip to content

Evome Medical Technologies, Inc.

CIK 0001617765

← back to feed
Revenue (TTM)
18.31M
+12,114.8% YoY FY Apr 2024
Net Income (TTM)
−1.32M
+1.8% YoY FY Apr 2024
EPS Diluted (TTM)
−0.05
+27.6% YoY FY Apr 2024
Gross Margin
111.9%
FY Apr 2024
Operating Margin
-25.9%
FY Apr 2024
Net Margin
-7.2%
FY Apr 2024
Free Cash Flow (TTM)
−3.35M
FY Apr 2024
Cash
918.68K
FY Apr 2024
Total Debt
10.67M
FY Apr 2024
Shares Outstanding
57.83M sh
FY Apr 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings